BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32695536)

  • 1. Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib.
    Khalil S; Ghafoor T; Raja AKF
    Case Rep Oncol Med; 2020; 2020():6923103. PubMed ID: 32695536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rare Case of Incidentally Diagnosed Pulmonary Inflammatory Myofibroblastic Tumour with Dramatic Response to Crizotinib in a Postpartum Woman.
    Yorke J; Solanki K; Theegala V; Georges T; Sinha AK; Asberry DE; El Abbassi A
    Eur J Case Rep Intern Med; 2023; 10(4):003626. PubMed ID: 37051474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring
    Zhao T; Zhang X; Liu X; Ren M; Cheng Y; Wang J; Luo Z
    Front Oncol; 2023; 13():1147974. PubMed ID: 37035208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report.
    Nagumo Y; Maejima A; Toyoshima Y; Komiyama M; Yonemori K; Yoshida A; Fujimoto H
    Int J Surg Case Rep; 2018; 48():1-4. PubMed ID: 29758320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained complete response on crizotinib in primary lung inflammatory myofibroblastic tumor - Case report and literature review.
    Mittal A; Gupta A; Dhamija E; Barwad A; Rastogi S
    Monaldi Arch Chest Dis; 2021 Mar; 91(3):. PubMed ID: 33794589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic Lymphoma Kinase (ALK)-Negative Inflammatory Myofibroblastic Tumor of the Kidney in a Nine-Month-Old Girl.
    Tareen B; Faith H; Waheed A; Ullah A; Kavuri SK
    Cureus; 2022 Mar; 14(3):e23289. PubMed ID: 35449656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent infantile inflammatory myofibroblastic tumor of mesentery--Case report and review of imaging findings.
    Gupta A; Sharma S; Mittal A; Barwad A; Rastogi S
    Radiol Case Rep; 2021 Mar; 16(3):504-510. PubMed ID: 33363692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crizotinib in ALK
    Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelioid Inflammatory Myofibroblastic Sarcoma With Poor Response to Crizotinib: A Case Report.
    Aminimoghaddam S; Pourali R
    Clin Med Insights Case Rep; 2023; 16():11795476231163954. PubMed ID: 37841512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring
    Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS
    Front Oncol; 2022; 12():761558. PubMed ID: 35237506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review.
    Singh P; Nambirajan A; Gaur MK; Raj R; Kumar S; Malik PS; Jain D
    J Pathol Transl Med; 2022 Jul; 56(4):231-237. PubMed ID: 35843628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor.
    Mai S; Xiong G; Diao D; Wang W; Zhou Y; Cai R
    Lung Cancer; 2019 Feb; 128():101-104. PubMed ID: 30642440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.
    Ogata M; Hatachi Y; Ogata T; Satake H; Imai Y; Yasui H
    Intern Med; 2019 Apr; 58(7):1029-1032. PubMed ID: 30449794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Myofibroblastic Tumor With Rapid Recurrence and Distant Metastasis: Report of a Rare Case.
    Kalita D; Rastogi R; Bhatnagar G; Medhi K; Pandey SK
    Cureus; 2024 Jan; 16(1):e52069. PubMed ID: 38344482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory myofibroblastic tumor in children: diagnosis and treatment.
    Karnak I; Senocak ME; Ciftci AO; Cağlar M; Bingöl-Koloğlu M; Tanyel FC; Büyükpamukçu N
    J Pediatr Surg; 2001 Jun; 36(6):908-12. PubMed ID: 11381424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Cases of Infantile Intra-abdominal Inflammatory Myofibroblastic Tumor.
    Kim SH; Cho YH; Kim HY
    Pediatr Gastroenterol Hepatol Nutr; 2014 Jun; 17(2):116-20. PubMed ID: 25061588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular Inflammatory Myofibroblastic Tumor: A Known Entity at a Very Rare Site.
    Voelker HU; Kuehn D; Strehl A; Kircher S
    Case Rep Urol; 2017; 2017():1410843. PubMed ID: 29430318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inflammatory myofibroblastic tumor of the small intestine presenting as jejunojejunal intussusception; A case report.
    Moges TG; Nureta TH; Mohammed TP
    Int J Surg Case Rep; 2023 Jul; 108():108404. PubMed ID: 37336176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib.
    Sunga CGG; Higgins MS; Ricciotti RW; Liu YJ; Cranmer LD
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1792. PubMed ID: 36754839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.